MTD:NYE-Mettler-Toledo International Inc (USD)

COMMON STOCK | Diagnostics & Research |

Last Closing

USD 1091.13

Change

-8.88 (-0.81)%

Market Cap

N/A

Volume

0.23M

Analyst Target

USD 865.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-05 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

-1.65 (-0.83%)

USD 135.03B
A Agilent Technologies Inc

-0.26 (-0.24%)

USD 29.28B
IQV IQVIA Holdings Inc

-1.18 (-0.77%)

USD 25.66B
LH Laboratory Corporation of Amer..

-0.84 (-0.34%)

USD 18.53B
DGX Quest Diagnostics Incorporated

-0.38 (-0.21%)

USD 18.18B
QGEN Qiagen NV

-0.32 (-0.74%)

USD 8.27B
CRL Charles River Laboratories

+0.98 (+0.83%)

USD 4.90B
ENZ Enzo Biochem Inc

N/A

USD 0.02B
TMO Thermo Fisher Scientific Inc

-1.28 (-0.30%)

N/A
WAT Waters Corporation

-2.07 (-0.59%)

N/A

ETFs Containing MTD

MCSE Martin Currie Sustainable.. 5.12 % 0.00 %

+0.01 (+0%)

N/A
EPRE 4.58 % 0.00 %

N/A

N/A
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.39 % 0.00 %

+0.03 (+0%)

N/A
XMLC:F L&G Clean Water UCITS ETF 2.27 % 0.00 %

+0.08 (+0%)

N/A
XLVE:CA 1.82 % 0.00 %

N/A

N/A
HECO SPDR Galaxy Hedged Digita.. 0.00 % 0.95 %

-0.34 (0%)

N/A
IBB iShares Biotechnology ETF 0.00 % 0.47 %

-0.74 (0%)

USD 5.43B
QRI:CA 0.00 % 1.06 %

N/A

N/A
YXM.B:CA 0.00 % 0.69 %

N/A

N/A
XSSX:LSE Xtrackers - Euro Stoxx 50.. 0.00 % 0.00 %

N/A

USD 0.04B
MJJ 0.00 % 0.00 %

N/A

N/A
MJO 0.00 % 0.00 %

N/A

N/A
DWEQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -10.83% 67% D+ 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -10.83% 67% D+ 20% F
Trailing 12 Months  
Capital Gain -12.77% 58% F 22% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -12.77% 58% F 19% F
Trailing 5 Years  
Capital Gain 52.48% 73% C 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 52.48% 73% C 45% F
Average Annual (5 Year Horizon)  
Capital Gain 9.22% 83% B 67% D+
Dividend Return 9.22% 83% B 61% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 25.88% 58% F 38% F
Risk Adjusted Return 35.62% 83% B 52% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike